08:56 AM EDT, 09/04/2025 (MT Newswires) -- Health care stocks were steady premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) slightly declining and the iShares Biotechnology ETF (IBB) inactive.

Sanofi ( SNY ) reported positive late-stage trial results of its experimental drug for the skin condition atopic dermatitis but according to news outlets, the improvement was less than Dupixent, Sanofi's ( SNY ) current top-selling drug for the same condition. Shares of Sanofi ( SNY ) were down more than 8% pre-bell.